Mirtazapine
Brand names: Remeron, Remeron SolTab
Tetracyclic Antidepressants (TeCA)Key Takeaway
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
⚠ FDA Black Box Warning
WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS — Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of mirtazapine or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior.
Emergency Information
Poison Control: 1-800-222-1222
How does Mirtazapine work?
Mirtazapine has a unique mechanism that sets it apart from SSRIs and SNRIs. Rather than blocking reuptake of neurotransmitters, mirtazapine works by blocking presynaptic alpha-2 adrenergic autoreceptors and heteroreceptors, which normally act as brakes on norepinephrine and serotonin release [1, 3].
By removing these brakes, mirtazapine enhances the release of both norepinephrine and serotonin. It is classified as a noradrenergic and specific serotonergic antidepressant (NaSSA) [1, 3].
Critically, mirtazapine also blocks 5-HT2A, 5-HT2C, and 5-HT3 serotonin receptors. This receptor blockade is clinically important because it means that even though serotonin levels increase, the side effects typically associated with serotonergic drugs — such as sexual dysfunction, nausea, and anxiety — are significantly reduced [1, 3, 4].
Mirtazapine is also a potent histamine H1 receptor antagonist, which accounts for its strong sedative effect and appetite stimulation. This makes it particularly valuable for depressed patients with insomnia and weight loss [1, 3].
In the **STAR*D trial**, mirtazapine was one of the options for later treatment steps, and combination strategies pairing mirtazapine with SSRIs or SNRIs (sometimes called "California rocket fuel") showed promise for treatment-resistant depression [5].
What to expect when starting Mirtazapine
Weeks 1-2: Start at 15 mg at bedtime. Significant sedation is expected and is actually desirable for patients with insomnia. Increased appetite and dry mouth are common. You will likely sleep better almost immediately. Improvement in mood typically lags behind [1, 3].
Weeks 2-4: Appetite stimulation continues; some weight gain may occur. Sedation may partially diminish. Your doctor may increase to 30 mg. Paradoxically, higher doses may cause less sedation due to increased noradrenergic activity [1].
Weeks 4-8: Full antidepressant effects emerge. Weight gain averages 2-3 kg over 6-8 weeks. Sexual side effects are notably less common than with SSRIs — a key advantage [4, 6].
Long-term: Weight gain may continue and is the most common reason patients discontinue mirtazapine. Metabolic monitoring (weight, glucose, lipids) is recommended. However, for patients who tolerate it, remission rates are favorable [1, 5].
What are the common side effects of Mirtazapine?
Common
- Somnolence/drowsiness54%
- Increased appetite17%
- Weight gain12% (mean 2-3 kg in 6-8 weeks)
- Dry mouth25%
- Dizziness7%
- Constipation13%
- Abnormal dreams4%
- Peripheral edema2%
- Elevated cholesterol15%
- Elevated triglycerides6%
What are the serious side effects of Mirtazapine?
Serious
- Mania/hypomania activationUncommon; higher risk in undiagnosed bipolar disorder
- Hepatotoxicity (elevated transaminases)Rare; mild ALT elevations in ~2% of patients
- Suicidal thoughts/behavior (in patients under 25)Approximately 4% vs 2% with placebo in clinical trials
- Serotonin syndrome (when combined with serotonergic drugs)Rare with monotherapy; risk increases significantly with SSRIs/SNRIs
- Agranulocytosis (severe neutropenia)Rare (~1 in 1000 in premarketing data); no confirmed cases post-marketing
- Severe allergic reactions (Stevens-Johnson syndrome)Very rare
What drugs interact with Mirtazapine?
- ContraindicatedMAOIs (phenelzine, tranylcypromine) — Do not use mirtazapine within 14 days of an MAOI. Risk of serotonin syndrome.
- ContraindicatedLinezolid (Zyvox) — Linezolid is a reversible MAOI. Concurrent use risks serotonin syndrome.
- ModerateSertraline (Zoloft) — Combining mirtazapine with SSRIs (California rocket fuel) is sometimes done intentionally for treatment-resistant depression but increases serotonin syndrome risk. Requires close monitoring.
- ModerateVenlafaxine (Effexor) — Combined SNRI + mirtazapine is used for treatment-resistant depression but increases serotonin syndrome risk.
- MajorAlcohol — Mirtazapine potentiates alcohol's CNS depressant effects. Cognitive and motor impairment is significantly enhanced.
- ModerateBenzodiazepines (alprazolam, lorazepam) — Additive CNS depression with benzodiazepines. Increased sedation, cognitive impairment. Use cautiously.
- ModerateCarbamazepine (Tegretol) — Carbamazepine is a CYP3A4 inducer that can decrease mirtazapine levels by up to 60%. Dose adjustment may be needed.
- ModerateKetoconazole — Strong CYP3A4 inhibitors like ketoconazole can increase mirtazapine levels. Monitor for excessive sedation.
Can I eat certain foods or drink alcohol with Mirtazapine?
Mirtazapine can be taken with or without food; food does not significantly affect its absorption [1].
Alcohol: Alcohol should be strictly avoided with mirtazapine. The combination produces profound additive CNS depression — significantly more than with SSRIs. Studies show that mirtazapine impairs cognitive function and motor skills to a degree comparable to benzodiazepines, and alcohol greatly amplifies this effect [1, 3].
Grapefruit: Mirtazapine is partially metabolized by CYP3A4. Large quantities of grapefruit juice could theoretically increase mirtazapine levels, though clinically significant interactions are unlikely with normal consumption [1].
Caffeine: No significant pharmacokinetic interaction. Caffeine may partially offset mirtazapine's sedative effects, though this is variable [1].
Carbohydrate cravings: Mirtazapine commonly increases appetite, particularly for carbohydrate-rich foods. This is related to 5-HT2C receptor blockade and antihistamine effects. Patients should be counseled on maintaining a balanced diet [1, 3].
What is the typical dosage for Mirtazapine?
Starting dose: 15 mg once daily at bedtime [1].
Usual therapeutic dose: 15-45 mg/day. Dose increases should be made in 15 mg increments at intervals of no less than 1-2 weeks [1].
Maximum dose: 45 mg/day [1].
Dose-sedation paradox: At 15 mg, antihistamine effects predominate (more sedation). At 30-45 mg, noradrenergic activation partially counteracts sedation. Patients who find 15 mg too sedating may actually tolerate 30 mg better [1, 3].
SolTab (orally disintegrating tablet): Place on tongue; it dissolves in approximately 30 seconds. Can be taken with or without water. Useful for patients with swallowing difficulties [1].
Renal impairment: Clearance reduced by 30% in moderate impairment, 50% in severe impairment. Use caution and consider lower doses [1].
Hepatic impairment: Clearance reduced by approximately 30%. Use lower doses [1].
Elderly: Start at 7.5-15 mg. Elderly patients have 40% reduced clearance. More sensitive to sedation and orthostatic effects [1].
How much does Mirtazapine cost?
Generic mirtazapine is widely available and costs approximately $4-15/month compared to $200-400/month for brand-name Remeron [1].
Pharmacy discount programs: Generic mirtazapine is available on most $4 generic lists at major retailers (Walmart, Costco, Kroger). GoodRx coupons typically bring the cost to $3-8 for a 30-day supply [1].
Patient assistance programs: Organon (successor to the original manufacturer) may offer patient assistance. NeedyMeds.org lists available programs [1].
90-day supply: Mail-order pharmacies offer 90-day supplies at $8-15 total, further reducing costs [1].
Insurance: Generic mirtazapine is Tier 1 on virtually all formularies with the lowest copay. No prior authorization required [1].
Is Mirtazapine safe during pregnancy or breastfeeding?
Pregnancy: Mirtazapine data in pregnancy is more limited than for SSRIs like sertraline. Available studies have not shown a clear increase in major malformations, but the evidence base is smaller [1, 9]. Third-trimester exposure may cause neonatal adaptation syndrome. Mirtazapine is sometimes used when SSRI side effects (sexual dysfunction, nausea) are intolerable. Decisions should be individualized with the prescriber.
Breastfeeding: Mirtazapine is excreted in breast milk at low levels. The relative infant dose is approximately 1.5-2% of the maternal weight-adjusted dose, which is considered low [9, 10]. Limited case reports suggest no adverse effects in breastfed infants, but data is limited. SSRIs with more breastfeeding safety data (sertraline, paroxetine) may be preferred as first-line options during lactation [10].
Is there a generic version of Mirtazapine?
Bioequivalence: Generic mirtazapine tablets and orally disintegrating tablets (ODT) are FDA AB-rated as bioequivalent to brand Remeron and Remeron SolTab [1].
Clinical equivalence: Generic formulations contain the same active ingredient at the same strength. There is no clinical evidence of differences in efficacy between generic and brand mirtazapine [1].
Formulation options: Generic is available as standard tablets (7.5, 15, 30, 45 mg) and orally disintegrating tablets. The ODT form is convenient for patients with swallowing difficulty or nausea [1].
Cost difference: Brand Remeron: $200-400/month. Generic mirtazapine: $4-15/month [1].
For Caregivers
Sedation: Mirtazapine causes significant drowsiness, especially at lower doses (15 mg). Bedtime dosing is essential. Ensure the patient has a safe path to the bathroom at night. Fall risk increases, particularly in elderly patients [1, 3].
Appetite and weight: Monitor weight regularly. Mirtazapine's appetite-stimulating effect can be beneficial in underweight or elderly patients but problematic in others. Help ensure a balanced diet and regular physical activity [1].
Monitoring: Watch for signs of worsening depression, suicidal thoughts, and behavioral changes, especially in the first 2-3 months and after dose changes [1, 2].
Fever and sore throat: Rarely, mirtazapine can cause agranulocytosis (dangerously low white blood cell count). If the patient develops fever, sore throat, or mouth sores, contact the prescriber promptly for a blood count check [1].
Frequently asked questions about Mirtazapine
References
- [Regulatory] FDA prescribing information for Mirtazapine Tablets (Remeron). https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020415s029lbl.pdf Accessed 2026-02-15.
- [Regulatory] FDA: Suicidality in Children and Adolescents Being Treated With Antidepressant Medications. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/suicidality-children-and-adolescents-being-treated-antidepressant-medications Accessed 2026-02-15.
- [Clinical] Anttila SA, Leinonen EV. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. 2001;7(3):249-264. https://pubmed.ncbi.nlm.nih.gov/11607047/ Accessed 2026-02-15.
- [Clinical] Cipriani A et al. Comparative efficacy and acceptability of 21 antidepressant drugs. Lancet. 2018;391(10128):1357-1366. https://pubmed.ncbi.nlm.nih.gov/29477251/ Accessed 2026-02-15.
- [Clinical] Rush AJ et al. STAR*D report. Am J Psychiatry. 2006;163(11):1905-1917. https://pubmed.ncbi.nlm.nih.gov/17074942/ Accessed 2026-02-15.
- [Clinical] Montejo AL et al. Incidence of sexual dysfunction associated with antidepressant agents. J Clin Psychiatry. 2001;62(Suppl 3):10-21. https://pubmed.ncbi.nlm.nih.gov/11229449/ Accessed 2026-02-15.
- [Clinical] Watanabe N et al. Mirtazapine versus other antidepressive agents for depression. Cochrane Database Syst Rev. 2011;(12):CD006528. https://pubmed.ncbi.nlm.nih.gov/22161405/ Accessed 2026-02-15.
- [Clinical] Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120. https://pubmed.ncbi.nlm.nih.gov/15784664/ Accessed 2026-02-15.
- [Clinical] Huybrechts KF et al. Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med. 2014;370(25):2397-2407. https://pubmed.ncbi.nlm.nih.gov/24941178/ Accessed 2026-02-15.
- [Clinical] Weissman AM et al. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry. 2004;161(6):1066-1078. https://pubmed.ncbi.nlm.nih.gov/15169695/ Accessed 2026-02-15.
- [Regulatory] DailyMed: Mirtazapine tablet. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be09f47e-1528-4a7f-8704-f26eb7d6e064 Accessed 2026-02-15.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: